Replies to post #110095 on Biotech Values

[oc631]

To address the other portion of your post, should you, I, or others, rather than discounting the possibility of t-enox approval, consider it as fact, what would change?

Consider nothing as a fact but be open to looking at things differently. The approval of T-Enox would remove the cloud of uncertainty hanging over the stock and then the fight over IP would begin in earnest. What caused me to change my view? The odd timing of the lawsuit, and the claims within which infer (by MNTA) that Teva may very well know what they doing (using MNTA's IP) to make a viable product. Teva's goal is to get past the FDA and into the courtroom where they excel.